see Bios Life Slim and Clinical Studies :

Clinically Tested, Peer Accepted:

Studied at North America’s Leading Scientific and Medical Research Centers.

Unicity products have been extensively reviewed in peer reviewed clinical studies conducted at several of the most prestigious hospitals and universities in the US and globally. Unicity continues to dedicate a large portion of the company budget to continued science and research.

Unicity’s flagship product, BALANCE (Bios Life SLIM) meets the NCEP guidelines for first-line treatment of primary dyslipidemia. It has also been studied as an adjunct to statins.

Eleven Unicity Products including Bios Life are listed in the PDR (Physician’s Desk Reference).

Unicity products are manufactured in FDA-approved facilities under stringent good manufacturing practices (GMP), as defined by government regulatory procedures. Where applicable, patented and standardized ingredients are used in the formulating and production processes.

Bios Life UNICITY BALANCE – Clinical Studies:

Cleveland Clinic Trial by Dr. Dennis Sprecher
Published in Sprecher DL, Pearce GL (2002) Fiber-multivitamin combination therapy: a beneficial influence on lowdensity lipoprotein and homocysteine Metabolism 51, 1166-70.
Cleveland_Clinic_Trial_Dennis_Sprecher.pdf

Diabetes in Control Study #1 by Steven Freed and David Joffe
Published in Freed S, Joffe D (2000) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes Diabetes in Control 12-8.
Diabetes-in-Control-Study_Steven_Freed_David_Joffe.pdf

Diabetes in Control Study #2 by Steven Freed and David Joffe
Published in Freed S, Joffe D (2004) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes II Diabetes in Control 212, 17, and Verdegem P, Freed S, Joffe D (2005) The clinical impact of fiber supplementation for the reduction of postprandial blood glucose and reduction of complications from type-2 diabetes Diabetes 54, A425.
Diabetes_in_Control_Study_2.pdf

The Clinical Impact of Fiber Supplementation on Cardio-Vascular Risk Parameters in type-2 Diabetes.
Presented by Verdegem P, Freed S, Joffe D. in 6th International Conference on Atherosclerosis, Thrombosis and Vascular Biology. 2005. Washinton, DC, USA. The American Heart Association sent out a press release on the study results.
AbstractPoster-ADA-2005.pdf – (AHA) American-Heart-Association-Press-Release.pdf

The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Type-2 Diabetes.
Presented by Verdegem P, Freed S, Joffe D. in 65th Scientific Session American Diabetes Association. 2005. San Diego, CA, USA.
Poster-ADA-2005.pdf

Philippines Trial by Dr. Yumul
Presented by Balajadia E, Valerio A, Yumul N. Beneficial effects of Bios Life 2 (Dietary Fiber Supplement) in patients with dyslipidemia. in 34th Annual Convention of the Philippine College of Physicians. 2004.
Phillippines Trial Dr. Yumul.pdf

Utah Trial by Dr. Peter J.E. Verdegem
As published by Verdegem P (2007) Viscous soluble fiber combined with phytosterols and policosanol reduces LDL-c and increases HDL-c in hypercholesterolemia Current Topics in Neutraceutical Research.
Utah Trial.pdf

Utah Trial #2 by Dr. Peter J.E. Verdegem
As presented by Verdegem P, Duenas V, Duenas J, Burke E. LDL- and HLD-cholesterol optimization using phytonutrient combination therapy: first line intervention and adjunct therapy to statins in 1st Asian Preventive Cardiology & Cardiac Rehabilitation Conference. 2006. Hong Kong.
Presented at the 7th International Congress on Coronary Artery Disease, 2007, Venice, Italy.
Utah Trial 2.pdf

Pacific Rim Trial by Dr. Vincent Duenas
Published in Duenas V, Duenas J, Burke E, Verdegem P (2006) A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia ArteriosclerThrombVascBiol 26, e53-e107.
Pacific Rim Trial Vincent Duenas.pdf

A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia.
Presented by Duenas V, Duenas J, Burke E, Verdegem P. in 7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2006. Denver.
Poster-ATVB-2005-1.pdfPoster for total users group.pdfPoster Statin User Group.pdf

Texas Trial by Dr. Isabel Martinez
Presented by Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. in 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago.

SOURCE

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s